Typhoid Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Typhoid fever pipeline market research report provides comprehensive information on the therapeutics under development for Typhoid Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects.
Key Targets in the Typhoid Fever Pipeline Market
Key targets in the typhoid fever pipeline market are Capsular Vi Polysaccharide Antigen, Polysaccharide, and Streptococcus pneumoniae Pneumococcal Surface Protein A. Among them Capsular Vi Polysaccharide Antigen have the highest number of pipeline products.
Typhoid Fever Pipeline Market, by Targets
For more target insights, download a free report sample
Key RoA in the Typhoid Fever Pipeline Market
Key RoA in the typhoid fever pipeline market are Intramuscular, Oral, Subcutaneous, Cutaneous, and Parenteral. Intramuscular has the highest number of pipeline products.
Typhoid Fever Pipeline Market, by RoA
For more RoA insights, download a free report sample
Key Molecule Types in the Typhoid Fever Pipeline Market
Key molecule types in the typhoid fever pipeline market are Conjugate Vaccine, Recombinant Vector Vaccine, Live Attenuated Vaccine, Subunit Vaccine, and Toxoid Vaccine. Conjugate Vaccine has the highest number of pipeline products.
Typhoid Fever Pipeline Market, by Molecule Types
For more key molecule type insights, download a free report sample
Key Companies in the Typhoid Fever Pipeline Market
Key companies in the typhoid fever pipeline market are Prokarium Ltd, Protein Potential LLC, Enesi Pharma Ltd, Eubiologics Co Ltd, GlaxoSmithKline Plc, Indian Immunologicals Ltd, Matrivax Research & Development Corp, Novo Medi Sciences Pvt Ltd, Sanofi Pasteur SA, Shantha Biotechnics Pvt Ltd, and Walvax Biotechnology Co Ltd. Prokarium Ltd has the highest number of pipeline products.
Typhoid Fever Pipeline Market, by Companies
To know more about companies in the typhoid fever pipeline market, download a free report sample
Market report overview
Key targets | Capsular Vi Polysaccharide Antigen, Polysaccharide, and Streptococcus pneumoniae Pneumococcal Surface Protein A |
Key RoA | Intramuscular, Oral, Subcutaneous, Cutaneous, and Parenteral |
Key molecule types | Conjugate Vaccine, Recombinant Vector Vaccine, Live Attenuated Vaccine, Subunit Vaccine, and Toxoid Vaccine |
Key companies | Prokarium Ltd, Protein Potential LLC, Enesi Pharma Ltd, Eubiologics Co Ltd, GlaxoSmithKline Plc, Indian Immunologicals Ltd, Matrivax Research & Development Corp, Novo Medi Sciences Pvt Ltd, Sanofi Pasteur SA, Shantha Biotechnics Pvt Ltd, and Walvax Biotechnology Co Ltd |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Typhoid Fever (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Typhoid Fever (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Typhoid Fever (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Typhoid Fever (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Typhoid Fever (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Typhoid Fever (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Typhoid Fever (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Eubiologics Co Ltd
GlaxoSmithKline Plc
Indian Immunologicals Ltd
Matrivax Research & Development Corp
Novo Medi Sciences Pvt Ltd
Prokarium Ltd
Protein Potential LLC
Sanofi Pasteur SA
Shantha Biotechnics Pvt Ltd
Walvax Biotechnology Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the typhoid fever pipeline market?
The key targets in the typhoid fever pipeline market are Capsular Vi Polysaccharide Antigen, Polysaccharide, and Streptococcus pneumoniae Pneumococcal Surface Protein A.
-
What are the key RoA in the typhoid fever pipeline market?
The key RoA in the typhoid fever pipeline market are Intramuscular, Oral, Subcutaneous, Cutaneous, and Parenteral.
-
What are the key molecule types in the typhoid fever pipeline market?
The key molecule types in the typhoid fever pipeline market are Conjugate Vaccine, Recombinant Vector Vaccine, Live Attenuated Vaccine, Subunit Vaccine, and Toxoid Vaccine.
-
What are the key companies in the typhoid fever pipeline market?
The key companies in the typhoid fever pipeline market are Prokarium Ltd, Protein Potential LLC, Enesi Pharma Ltd, Eubiologics Co Ltd, GlaxoSmithKline Plc, Indian Immunologicals Ltd, Matrivax Research & Development Corp, Novo Medi Sciences Pvt Ltd, Sanofi Pasteur SA, Shantha Biotechnics Pvt Ltd, and Walvax Biotechnology Co Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.